
|Articles|July 1, 2002
Topical shows persistence
Los Angeles - Preliminary results from a split-face, double-blind study are further substantiating the efficacy of a unique topical product containing growth factors and antioxidants for improving photodamaged skin and indicate that its effects persist and increase even after treatment is stopped, Richard E. Fitzpatrick, M.D., reported at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
Targeting MRGPRX2: Early Human Data for a Novel CSU Approach
3
What Counts as “Short-Term” Systemic Corticosteroids in Atopic Dermatitis, and Why It Matters
4
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
5










